During the past decade, Desert Medical Advances conducted 28 clinical trials. In the 10-year time frame, 28 clinical trials started and 35 clinical trials were completed, i.e. on average, 125% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 21 clinical trials were completed. i.e. 233.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Desert Medical Advances" #1 sponsor was "Eli Lilly and Company" with 13 trials, followed by "Pfizer" with 10 trials sponsored, "Bristol-Myers Squibb" with 6 trials sponsored, "Amgen" with 5 trials sponsored and "Galapagos NV" with 5 trials sponsored. Other sponsors include 18 different institutions and companies that sponsored additional 22 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Desert Medical Advances" #1 collaborator was "Gilead Sciences" with 2 trials as a collaborator, "Incyte Corporation" with 2 trials as a collaborator, "Affibody" with 1 trials as a collaborator, "Astra Zeneca, Bristol-Myers Squibb" with 1 trials as a collaborator and "Biogen" with 1 trials as a collaborator. Other collaborators include 1 different institutions and companies that were collaborators in the rest 11 trials.

According to Clinical.Site data, the most researched conditions in "Desert Medical Advances" are "Rheumatoid Arthritis" (24 trials), "Arthritis, Rheumatoid" (7 trials), "Psoriatic Arthritis" (5 trials), "Systemic Lupus Erythematosus" (4 trials) and "Ankylosing Spondylitis" (3 trials). Many other conditions were trialed in "Desert Medical Advances" in a lesser frequency.

Most popular intervention types in "Desert Medical Advances" are "Drug" (57 trials), "Biological" (6 trials), "Other" (5 trials) and "Genetic" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (32 trials), "Adalimumab" (5 trials), "Baricitinib" (5 trials), "Methotrexate" (5 trials) and "Ixekizumab" (4 trials). Other intervention names were less common.

The vast majority of trials in "Desert Medical Advances" are 57 trials for "All" genders and 4 trials for "Female" genders.

Currently, there are NaN active trials in "Desert Medical Advances". undefined are not yet recruiting, 2 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 49 completed trials in Desert Medical Advances, undefined suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in Desert Medical Advances, 2 "Phase 1" clinical trials were conducted, 29 "Phase 2" clinical trials and 24 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 1 trials that are defined as “Not Applicable".